Viewing Study NCT04944992


Ignite Creation Date: 2025-12-24 @ 3:45 PM
Ignite Modification Date: 2026-02-02 @ 12:05 PM
Study NCT ID: NCT04944992
Status: COMPLETED
Last Update Posted: 2023-11-15
First Post: 2021-06-28
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Nonalcoholic Fatty Liver Disease View
None Nonalcoholic Steatohepatitis View
Keywords: